BRAIN TUMOR, RECURRENT
Clinical trials for BRAIN TUMOR, RECURRENT explained in plain language.
Never miss a new study
Get alerted when new BRAIN TUMOR, RECURRENT trials appear
Sign up with your email to follow new studies for BRAIN TUMOR, RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells injected directly into brain to fight cancer
Disease control OngoingThis early-phase study is testing the safety of a new treatment for people with recurrent or treatment-resistant brain tumors that have a specific marker called HER2. Doctors take a patient's own immune cells (T cells), modify them in a lab to better recognize and attack the canc…
Matched conditions: BRAIN TUMOR, RECURRENT
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Apr 02, 2026 01:41 UTC
-
Antidepressant repurposed in fight against brain cancer
Disease control OngoingThis early-stage study is testing if a common antidepressant drug, fluoxetine (Prozac), can make a standard chemotherapy drug (temozolomide) more effective at killing recurrent brain tumor cells. The researchers want to see if fluoxetine causes stress inside cancer cells, making …
Matched conditions: BRAIN TUMOR, RECURRENT
Phase: EARLY_PHASE1 • Sponsor: Duke University • Aim: Disease control
Last updated Mar 04, 2026 15:30 UTC